These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31921440)

  • 21. Two Cases of Atezolizumab-Induced Hypophysitis.
    Kanie K; Iguchi G; Bando H; Fujita Y; Odake Y; Yoshida K; Matsumoto R; Fukuoka H; Ogawa W; Takahashi Y
    J Endocr Soc; 2018 Jan; 2(1):91-95. PubMed ID: 29362727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event.
    Doodnauth AV; Klar M; Mulatu YS; Malik ZR; Patel KH; McFarlane SI
    Cureus; 2021 Jun; 13(6):e15465. PubMed ID: 34123679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report.
    Furubayashi N; Negishi T; Uozumi T; Takamatsu D; Shiraishi K; Hirose D; Nakamura M
    Mol Clin Oncol; 2019 Feb; 10(2):304-308. PubMed ID: 30680212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary Adrenal Insufficiency Following Nivolumab Therapy in a Patient with Metastatic Renal Cell Carcinoma.
    Seki T; Yasuda A; Oki M; Kitajima N; Takagi A; Nakajima N; Miyajima A; Fukagawa M
    Tokai J Exp Clin Med; 2017 Sep; 42(3):115-120. PubMed ID: 28871578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitors.
    Iwamoto Y; Tatsumi F; Ohnishi M; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Mune T; Kaneto H
    Medicine (Baltimore); 2024 Mar; 103(10):e37204. PubMed ID: 38457550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nivolumab Induced Adrenal Insufficiency: Rare Side-effect of a New Anti-cancer Therapy - Immune-checkpoint Inhibitors.
    Rai M; Go M
    Cureus; 2020 Apr; 12(4):e7625. PubMed ID: 32399358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature.
    Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A
    BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. May primary empty sella turcica be a cause of isolated ACTH deficiency? A case report and the review of related literature.
    Gulcan E; Gulcan A; Taser F; Korkmaz U; Erbilen E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):745-8. PubMed ID: 18063931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.
    Iwayama H; Hirase S; Nomura Y; Ito T; Morita H; Otake K; Okumura A; Takagi J
    BMC Endocr Disord; 2018 Mar; 18(1):19. PubMed ID: 29587720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HYPOGLYCEMIA AS INITIAL PRESENTATION IN PATIENT WITH ISOLATED ACTH DEFICIENCY.
    Alabdrabalnabi FM; Al Saeed ZA; Elamin YA
    AACE Clin Case Rep; 2020; 6(6):e338-e341. PubMed ID: 33244498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare clinical problem - isolated ACTH deficiency associated with chronic alcohol abuse.
    Skowrońska-Jóźwiak E; Orzechowski S; Piętak W; Lewiński A
    Endokrynol Pol; 2022; 73(4):778-783. PubMed ID: 35971928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of secondary adrenal insufficiency: findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel.
    Lin SY; Won JG; Lee TI; Tang KT; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):156-63. PubMed ID: 12135194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of isolated ACTH deficiency who developed autoimmune-mediated hypothyroidism and impaired water diuresis during glucocorticoid replacement therapy.
    Kageyama Y
    Endocr J; 2000 Dec; 47(6):667-74. PubMed ID: 11228040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
    Kurokawa K; Mitsuishi Y; Shimada N; Ito N; Ogiwara M; Miura K; Asao T; Ko R; Shukuya T; Shibayama R; Goto H; Takahashi K
    Thorac Cancer; 2023 Feb; 14(5):442-449. PubMed ID: 36523162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report.
    Fujimiya T; Azuma K; Togashi Y; Kuwata K; Unezaki S; Takeuchi H
    J Pharm Health Care Sci; 2024 Feb; 10(1):10. PubMed ID: 38365819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab.
    Bekki T; Takakura Y; Kochi M; Konemori Y; Oki K; Yoneda M; Egi H; Ohdan H
    Case Rep Oncol; 2020; 13(1):200-206. PubMed ID: 32308578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New onset of isolated adrenocorticotropin deficiency associated with encephalopathy following coronavirus disease 2019 in a healthy elderly man.
    Yamasaki Y; Horie I; Shigeno R; Nishikido S; Ikeoka T; Hirayama T; Tateishi Y; Tsujino A; Kawakami A
    Endocr J; 2024 Mar; 71(3):305-312. PubMed ID: 38246654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated Adrenocorticotropic Hormone (ACTH) Deficiency as an Immune-Related Adverse Event Following Combination Immune Checkpoint Inhibitor Therapy.
    Matsushiro M; Shibue K; Osawa K; Hamasaki A
    Cureus; 2024 Jun; 16(6):e62863. PubMed ID: 39040756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.